You are looking to acquire a target company and need to validate its commercial claims and market position. You need an independent view before signing the deal.
Relying on the seller's Information Memorandum is risky. If the market growth or competitive position is overstated, you could overpay for an asset with limited potential.
We rigorously test the investment thesis through customer interviews, market sizing, and competitive analysis. We flag key commercial risks and upside opportunities.
You make an informed investment decision with a clear view of the target's true commercial health. You avoid bad deals and can negotiate price based on facts.